Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07011615 · ClinicalTrials.gov registry record · NA
Feasibility/Acceptability of a Brief Motivational Intervention for Frequent/High-Intensity Cannabis Use
A NA study of Cannabis Use, sponsored by University of Washington.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT07011615: Recruiting NA study of Cannabis Use, sponsored by University of Washington.
NCT07011615 is a NA study of Cannabis Use that is actively recruiting participants, run by University of Washington. The registered enrollment target is 120 participants, below the 277-participant average among 44 other Cannabis Use trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07011615, a NA study of Cannabis Use, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The study aims to develop a novel brief motivational mobile health (mHealth) intervention for frequent and/or high-intensity cannabis use for non-collegiate young adults. A total of 120 young adults (ages 18-29, not enrolled at or attending a 4-year college or university) will be randomized to receive a mHealth intervention with text messages for five weeks or to an online resource/program with psychoeducation information about cannabis. The mHealth intervention will focus on prompting the young adult to reflect on their journey with cannabis and to reflect on their personal goals and how cannabis is reflected in these goals. Additional mini-modules are included related to topics such as motivations for use, perceived norms and tracking cannabis use. Participants will return to the program each week to reflect on the prior week and reflect on goals for the upcoming week. All participants will complete a program satisfaction survey and complete follow-up assessments at 3- and 6-months post-program.
Primary Outcome
The count of the self-reported typical number of hours high per week during the past month
Conditions Studied
Interventions
- BEHAVIORAL Brief Motivational Mobile Health (mHealth) Intervention
- OTHER Psychoeducational Attention Control (AC)
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-12-08 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT07011615 shows while recruiting
NCT07011615 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 277-participant average among 44 other Cannabis Use trials with a reported enrollment target (57% lower).
The record links to 1 condition, with Cannabis Use appearing as the primary indexed condition, and to 2 interventions - of which Brief Motivational Mobile Health (mHealth) Intervention is the first listed.
NCT07011615 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT07011615 about?
NCT07011615 is a clinical study titled "Feasibility/Acceptability of a Brief Motivational Intervention for Frequent/High-Intensity Cannabis Use". The study aims to develop a novel brief motivational mobile health (mHealth) intervention for frequent and/or high-intensity cannabis use for non-collegiate young adults. A total of 120 young adults (ages 18-29, not enrolled at or attending a 4-year college or university) will be randomized to recei...
What is the current status of trial NCT07011615?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-12-08. Estimated completion is 2026-12.
What conditions does trial NCT07011615 study?
This clinical trial studies the following conditions: Cannabis Use.
What interventions are being tested in trial NCT07011615?
The interventions under investigation include: Brief Motivational Mobile Health (mHealth) Intervention (BEHAVIORAL), Psychoeducational Attention Control (AC) (OTHER).
Who is sponsoring clinical trial NCT07011615?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07011615 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cannabis Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07011615's enrollment target sits among peer trials
120 20th of 44 higher than 25 of 44 other Cannabis Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cannabis Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Distinguishing Alcohol Intoxication, Cannabis Intoxication and Co-intoxication Using Electroencephalography (EEG)
RECRUITING · NA
-
Mobile Intervention for Simultaneous Alcohol and Marijuana Use in Young Adults
RECRUITING · NA
-
Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia
RECRUITING · NA
-
Cannabis THC Potency, Metabolism, and Cognitive Impairment in Young Adults
RECRUITING · NA
-
Stress and Resilience
RECRUITING · NA
-
Perceptual Influences From Smoking Cannabis: an Experimental Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI